MDGL today
$425.21-$7.82 (-1.81%)close Nov 12, 2026Trend
DailyDowntrend (starting)
4 hourLeaning Bearish
1 hourBearish
15 minLeaning Bearish
5 minConsolidating
Daily trend turns up above $572.20
Key levels
Resistance$481.87
Resistance$443.48
Support$418.72
Support$393.61
Latest news & SEC filings
SEC FilingMadrigal Pharmaceuticals, Inc. filed an insider trading report (Form 4)
LegalLaw firms investigate possible securities violations after whistleblower complaint
All MDGL news →About Madrigal Pharmaceuticals
Madrigal Pharmaceuticals is a biopharmaceutical company that develops medicines for a serious fatty liver condition known as MASH. Its approved drug, Rezdiffra, is an oral treatment for adults with liver scarring from this disease, and it is sold in the United States and Germany. The company is also developing other drug candidates, including a pill that acts on gut hormone pathways, an enzyme blocker, and several gene-silencing programs, to treat this liver disease.
Based on the company's 10-K filed Feb 19, 2026.
Nasdaq · Healthcare
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
What Is the Price Target for MDGL?
SEPT Low Target
$542.00
SEPT Mid Target
$667.00
SEPT High Target
$962.00
Analyst Consensus
$667.00
Is MDGL a Buy or Sell Right Now?
Thesis
- •Revenue growing 432.1% YoY with UNKNOWN trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for MDGL.
Start Free Trial →Is MDGL Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$511.68
4
Moat Score
NONE
3/9
Piotroski Score
9.7
Altman Z-Score
What Is Smart Money Doing with MDGL?
Insider Signal
SELLING
0 buys / 20 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Kelley Shannon T | officer | Sale | 1,077 | $431K | Nov 6, 2026 |
| BAKER BROS. ADVISORS LP | director | Buy | 60,400 | $23.1M | Nov 6, 2026 |
| BAKER BROS. ADVISORS LP | director | Buy | 13,740 | $5.3M | Nov 6, 2026 |
| BAKER BROS. ADVISORS LP | director | Buy | 2,000 | $793K | Nov 6, 2026 |
| BAKER BROS. ADVISORS LP | director | Buy | 5,586 | $2.1M | Nov 4, 2026 |
| BAKER BROS. ADVISORS LP | director | Buy | 10,080 | $3.7M | Nov 4, 2026 |
| Sibold William John | director officer | Sale | 60 | $32K | Sep 11, 2026 |
| Sibold William John | director officer | Sale | 106 | $57K | Sep 11, 2026 |
| Sibold William John | director officer | Sale | 218 | $117K | Sep 11, 2026 |
| Sibold William John | director officer | Sale | 160 | $86K | Sep 11, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →MDGL Growth Story
Revenue YoY
432.1%
3yr Revenue CAGR
N/A%
EPS Growth YoY
41.36%
FCF Growth YoY
58.4%
Revenue Trend
UNKNOWN
Dark Pool Trades for MDGL
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for MDGL, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:00:06 | $425.21 | 115,544 | $$49.1M | SELL |
| 17:15:06 | $430.19 | 9,635 | $$4.1M | SELL |
| 21:26:13 | $433.03 | 1,502 | $$650K | BUY |
| 21:44:52 | $432.60 | 2,080 | $$900K | BUY |
| 21:44:46 | $432.60 | 2,080 | $$900K | BUY |
5 dark pool trades shown · $$55.7M preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for MDGL
PREVIEWSEPT Investing provides real-time options flow tracking for MDGL, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| PUT | $560 | Mar 19 | 127 | $$113.9K | 8 | REGULAR |
| PUT | $560 | Mar 19 | 127 | $$128.2K | 9 | SWEEP |
| PUT | $560 | Mar 19 | 127 | $$113.9K | 8 | SWEEP |
| PUT | $560 | Mar 19 | 127 | $$114.1K | 8 | REGULAR |
| PUT | $560 | Mar 19 | 127 | $$128.3K | 9 | SWEEP |
5 options trades shown · 0% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for MADRIGAL PHARMACEUTICALS, INC. (MDGL) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (5 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →MDGL — frequently asked questions
What is MDGL stock price today?
MADRIGAL PHARMACEUTICALS, INC. (MDGL) is at $425.21, down 1.81% (-$7.82) at the Nov 12, 2026 close.
Why is MDGL stock moving today?
Latest MDGL news — Nov 6, 2026: Madrigal Pharmaceuticals, Inc. filed an insider trading report (Form 4) · Nov 5, 2026: Law firms investigate possible securities violations after whistleblower complaint
What is the MDGL price target?
The average analyst price target for MDGL is $667.00, ranging from $542 to $962, based on 10 analysts. Latest: Citigroup maintains on Nov 3, 2026.
What do analysts rate MDGL?
Analyst ratings for MDGL: 2 Buy, 9 Hold, 0 Sell — consensus Hold.
Did MDGL beat earnings?
MDGL last reported on Nov 3, 2026: EPS $1.83 vs -$0.86 expected — a beat of 312.1%.
Does MDGL pay a dividend?
MDGL does not currently pay a dividend.
How much debt does MDGL have?
MADRIGAL PHARMACEUTICALS, INC. reported $341M of debt and $293M of cash (Jun 30, 2026).
What are MDGL support and resistance levels?
Support: $418.72, $393.61, $353.54. Resistance: $443.48, $481.87, $519.10.
What are insiders doing with MDGL?
Insider activity: SELLING, 0 buys and 20 sells in the last 90 days.
What is the latest news on MDGL?
Nov 6, 2026: Madrigal Pharmaceuticals, Inc. filed an insider trading report (Form 4) · Nov 5, 2026: Law firms investigate possible securities violations after whistleblower complaint